Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Frontiers in Allergy
|
October 9, 2025
Correction: Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study
Yoshitomo Kushima, Yasuo Shimizu, Ryo Arai, et al.
Journal of Gastroenterology
|
April 20, 2026
Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinoma
Tomohiko Ikehara, Hajime Otsu, Taro Tobo, et al.
Scientific Reports
|
March 3, 2026
Multicenter ex vivo evaluation of an α-mannosidase-targeted fluorescent probe for intraoperative margin assessment in breast cancer
Hiroki Ueo, Hiroaki Ueo, Takako Doi, et al.
Cancer Science
|
March 18, 2024
Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer
Masahiro Hashimoto, Takaaki Masuda, Yusuke Nakano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 14, 2026
Identification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular Carcinoma
Kiyotaka Hosoda, Takaaki Masuda, Hideyuki Saito, et al.
Cancer Science
|
June 30, 2026
NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2
Tomohiko Ikehara, Hajime Otsu, Taro Tobo, et al.
BMC Medicine
|
November 17, 2018
Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design
Munyaradzi Dimairo, Elizabeth Coates, Philip Pallmann, et al.
Trials
|
June 18, 2020
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
Munyaradzi Dimairo, Philip Pallmann, James Wason, et al.
BMJ (Clinical Research Ed.)
|
June 20, 2020
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
Munyaradzi Dimairo, Philip Pallmann, James Wason, et al.
Cancer Science
|
October 22, 2025
ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation
Tadashi Abe, Takaaki Masuda, Taro Tobo, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Frontiers in Allergy
|
October 9, 2025
Correction: Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study
Yoshitomo Kushima, Yasuo Shimizu, Ryo Arai, et al.
Journal of Gastroenterology
|
April 20, 2026
Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinoma
Tomohiko Ikehara, Hajime Otsu, Taro Tobo, et al.
Scientific Reports
|
March 3, 2026
Multicenter ex vivo evaluation of an α-mannosidase-targeted fluorescent probe for intraoperative margin assessment in breast cancer
Hiroki Ueo, Hiroaki Ueo, Takako Doi, et al.
Cancer Science
|
March 18, 2024
Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer
Masahiro Hashimoto, Takaaki Masuda, Yusuke Nakano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 14, 2026
Identification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular Carcinoma
Kiyotaka Hosoda, Takaaki Masuda, Hideyuki Saito, et al.
Cancer Science
|
June 30, 2026
NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2
Tomohiko Ikehara, Hajime Otsu, Taro Tobo, et al.
BMC Medicine
|
November 17, 2018
Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design
Munyaradzi Dimairo, Elizabeth Coates, Philip Pallmann, et al.
Trials
|
June 18, 2020
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
Munyaradzi Dimairo, Philip Pallmann, James Wason, et al.
BMJ (Clinical Research Ed.)
|
June 20, 2020
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
Munyaradzi Dimairo, Philip Pallmann, James Wason, et al.
Cancer Science
|
October 22, 2025
ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation
Tadashi Abe, Takaaki Masuda, Taro Tobo, et al.
Page
of 7